https://www.selleckchem.com/products/LBH-589.html
753, = 0.041), anxiety (OR = 7.714, = 0.009), neuropathic pain (OR = 11.261, = 0.022), sensory neuropathy (OR = 2.529, = 0.032), motor neuropathy (OR = 3.781, = 0.002), and undergoing chemotherapy (OR = 2.593, = 0.027). Targeted therapy that some survivors received served as a protective factor (OR = 0.351, = 0.015). We found a high prevalence of poor sleep quality in breast cancer survivors treated with docetaxel. The results indicated that, in addition to clinical characteristics and psychological discomfort, chemotherapy-induced peri
Kao
Komentar
Udio
